• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠模型中过继性CIK细胞移植免疫治疗乳腺癌的F-FHBG PET-CT报告基因成像

F-FHBG PET-CT Reporter Gene Imaging of Adoptive CIK Cell Transfer Immunotherapy for Breast Cancer in a Mouse Model.

作者信息

Li Xiaofeng, Yin Guotao, Ji Wei, Liu Jianjing, Zhang Yufan, Wang Jian, Zhu Xiang, Zhu Lei, Dai Dong, Ma Wenchao, Xu Wengui

机构信息

Department of Molecular Imaging and Nuclear Medicine, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, People's Republic of China.

Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, People's Republic of China.

出版信息

Onco Targets Ther. 2020 Nov 13;13:11659-11668. doi: 10.2147/OTT.S271657. eCollection 2020.

DOI:10.2147/OTT.S271657
PMID:33223839
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7671474/
Abstract

BACKGROUND

To further improve the efficiency of adoptively transferred cytokine-induced killer (CIK) cell immunotherapy in breast cancer (BC), a reliable imaging method is required to visualize and monitor these transferred cells in vivo.

METHODS

Herpes simplex virus 1-thymidine kinase () and 9-(4-[F]fluoro-3-(hydroxymethyl)butyl)guanine (F-FHBG) were used as a pair of reporter gene/reporter probe for positron emission tomography (PET) imaging in this study. Following the establishment of subcutaneous BC xenograft-bearing nude mice models, induced human CIK cells expressing reporter gene through lentiviral transduction were intravenously injected to nude mice. γ-radioimmunoassay was used to determine the specific uptake of F-FHBG by these genetically engineered CIK cells expressing in vitro, and F-FHBG micro positron emission tomography-computed tomography (PET-CT) imaging was performed to visualize these adoptively transferred CIK cells in tumor-bearing nude mice.

RESULTS

Specific uptake of F-FHBG by CIK cells expressing was clearly observed in vitro. Consistently, the localization of adoptively transferred CIK cells in tumor target could be effectively visualized by F-FHBG micro PET-CT reporter gene imaging.

CONCLUSION

PET-CT reporter gene imaging using F-FHBG as a reporter probe enables the visualization and monitoring of adoptively transferred CIK cells in vivo.

摘要

背景

为进一步提高过继性转移细胞因子诱导的杀伤细胞(CIK)免疫疗法治疗乳腺癌(BC)的效率,需要一种可靠的成像方法在体内可视化并监测这些转移细胞。

方法

在本研究中,单纯疱疹病毒1-胸苷激酶()和9-(4-[F]氟-3-(羟甲基)丁基)鸟嘌呤(F-FHBG)被用作一对用于正电子发射断层扫描(PET)成像的报告基因/报告探针。在建立皮下荷人BC异种移植瘤裸鼠模型后,将通过慢病毒转导表达报告基因的诱导人CIK细胞静脉注射到裸鼠体内。采用γ放射免疫测定法测定这些体外表达的基因工程CIK细胞对F-FHBG的特异性摄取,并进行F-FHBG微型正电子发射断层扫描-计算机断层扫描(PET-CT)成像,以可视化荷瘤裸鼠体内这些过继性转移的CIK细胞。

结果

体外可清楚观察到表达的CIK细胞对F-FHBG的特异性摄取。同样,通过F-FHBG微型PET-CT报告基因成像可有效可视化过继性转移的CIK细胞在肿瘤靶点的定位。

结论

以F-FHBG作为报告探针的PET-CT报告基因成像能够在体内可视化并监测过继性转移的CIK细胞。

相似文献

1
F-FHBG PET-CT Reporter Gene Imaging of Adoptive CIK Cell Transfer Immunotherapy for Breast Cancer in a Mouse Model.小鼠模型中过继性CIK细胞移植免疫治疗乳腺癌的F-FHBG PET-CT报告基因成像
Onco Targets Ther. 2020 Nov 13;13:11659-11668. doi: 10.2147/OTT.S271657. eCollection 2020.
2
Molecular-genetic PET imaging using an HSV1-tk mutant reporter gene with enhanced specificity to acycloguanosine nucleoside analogs.使用对阿昔洛韦核苷类似物具有增强特异性的HSV1-tk突变报告基因进行分子遗传PET成像。
J Nucl Med. 2009 Mar;50(3):409-16. doi: 10.2967/jnumed.108.058735. Epub 2009 Feb 17.
3
[Molecular imaging for PET-CT reporter gene in breast adenocarcinoma (HSV1-tk) of subcutaneous xenografts in living nude mice].[活体裸鼠皮下移植瘤乳腺癌(HSV1-tk)中PET-CT报告基因的分子成像]
Zhonghua Yi Xue Za Zhi. 2009 Dec 29;89(48):3420-4.
4
PET of cardiac transgene expression: comparison of 2 approaches based on herpesviral thymidine kinase reporter gene.心脏转基因表达的正电子发射断层扫描:基于疱疹病毒胸苷激酶报告基因的两种方法的比较
J Nucl Med. 2004 Nov;45(11):1917-23.
5
9-(4-[F]Fluoro-3-hydroxymethylbutyl)guanine9 -(4 - [氟]氟 - 3 - 羟甲基丁基)鸟嘌呤
6
Synthesis and Characterization of 9-(4-[F]Fluoro-3-(hydroxymethyl)butyl)-2-(phenylthio)-6-oxopurine as a Novel PET Agent for Mutant Herpes Simplex Virus Type 1 Thymidine Kinase Reporter Gene Imaging.新型 PET 显像剂 9-(4-[F]氟-3-(羟甲基)丁基)-2-(苯硫基)-6-氧代嘌呤的合成与表征用于突变型单纯疱疹病毒 1 胸苷激酶报告基因显像。
Mol Imaging Biol. 2020 Oct;22(5):1151-1160. doi: 10.1007/s11307-020-01517-5.
7
Comparison of [18F]FHBG and [14C]FIAU for imaging of HSV1-tk reporter gene expression: adenoviral infection vs stable transfection.[18F]FHBG与[14C]FIAU用于单纯疱疹病毒1型胸苷激酶(HSV1-tk)报告基因表达成像的比较:腺病毒感染与稳定转染
Eur J Nucl Med Mol Imaging. 2003 Nov;30(11):1547-60. doi: 10.1007/s00259-003-1238-6. Epub 2003 Jul 10.
8
A new acycloguanosine-specific supermutant of herpes simplex virus type 1 thymidine kinase suitable for PET imaging and suicide gene therapy for potential use in patients treated with pyrimidine-based cytotoxic drugs.一种新型的单纯疱疹病毒1型胸苷激酶的无环鸟苷特异性超突变体,适用于正电子发射断层扫描(PET)成像和自杀基因治疗,可能用于接受嘧啶类细胞毒性药物治疗的患者。
J Nucl Med. 2008 May;49(5):713-20. doi: 10.2967/jnumed.107.046425. Epub 2008 Apr 15.
9
A tracer kinetic model for 18F-FHBG for quantitating herpes simplex virus type 1 thymidine kinase reporter gene expression in living animals using PET.一种用于18F-FHBG的示踪动力学模型,用于使用正电子发射断层扫描(PET)定量活体动物中单纯疱疹病毒1型胸苷激酶报告基因的表达。
J Nucl Med. 2004 Sep;45(9):1560-70.
10
Semiautomated radiosynthesis and biological evaluation of [18F]FEAU: a novel PET imaging agent for HSV1-tk/sr39tk reporter gene expression.[18F]FEAU的半自动放射性合成及生物学评价:一种用于HSV1-tk/sr39tk报告基因表达的新型PET成像剂
Mol Imaging Biol. 2008 Mar-Apr;10(2):82-91. doi: 10.1007/s11307-007-0122-3. Epub 2007 Dec 22.

引用本文的文献

1
Radionuclide Imaging of Cytotoxic Immune Cell Responses to Anti-Cancer Immunotherapy.抗癌免疫疗法细胞毒性免疫细胞反应的放射性核素成像
Biomedicines. 2022 May 5;10(5):1074. doi: 10.3390/biomedicines10051074.

本文引用的文献

1
Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives.HER2 阳性乳腺癌的免疫治疗:现状与未来展望。
J Hematol Oncol. 2019 Oct 29;12(1):111. doi: 10.1186/s13045-019-0798-2.
2
Potential clinical application of tumor-infiltrating lymphocyte therapy for ovarian epithelial cancer prior or post-resistance to chemotherapy.肿瘤浸润淋巴细胞治疗在卵巢上皮性癌化疗耐药前后的潜在临床应用。
Cancer Immunol Immunother. 2019 Nov;68(11):1747-1757. doi: 10.1007/s00262-019-02402-z. Epub 2019 Oct 10.
3
Trastuzumab-Induced Cardiomyopathy.曲妥珠单抗相关性心肌病。
Cardiol Clin. 2019 Nov;37(4):407-418. doi: 10.1016/j.ccl.2019.07.005. Epub 2019 Aug 27.
4
Overcoming Immunological Resistance Enhances the Efficacy of A Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma.克服免疫抵抗增强新型抗 tMUC1-CAR T 细胞治疗对胰腺导管腺癌的疗效。
Cells. 2019 Sep 11;8(9):1070. doi: 10.3390/cells8091070.
5
Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data.曲妥珠单抗单药一线治疗 HER-2+晚期乳腺癌的长期应答者:特征和生存数据。
BMC Cancer. 2019 Sep 10;19(1):902. doi: 10.1186/s12885-019-6105-3.
6
Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: results from the french real-life curie database.曲妥珠单抗一线治疗 HER2 阳性转移性乳腺癌的长期生存:法国真实世界居里数据库研究结果。
Breast Cancer Res Treat. 2019 Dec;178(3):505-512. doi: 10.1007/s10549-019-05423-5. Epub 2019 Sep 5.
7
Cullin7 enhances resistance to trastuzumab therapy in Her2 positive breast cancer via degrading IRS-1 and downregulating IGFBP-3 to activate the PI3K/AKT pathway.Cullin7 通过降解 IRS-1 和下调 IGFBP-3 来激活 PI3K/AKT 通路,从而增强 Her2 阳性乳腺癌对曲妥珠单抗治疗的耐药性。
Cancer Lett. 2019 Nov 1;464:25-36. doi: 10.1016/j.canlet.2019.08.008. Epub 2019 Aug 25.
8
Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells.平衡癌症免疫疗法和免疫相关不良事件:调节性 T 细胞的新作用。
J Autoimmun. 2019 Nov;104:102310. doi: 10.1016/j.jaut.2019.102310. Epub 2019 Aug 15.
9
Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8 T Cells and Synergizes with PI3Kβ Inhibition in PTEN Loss Melanoma.抗 OX40 抗体直接增强肿瘤反应性 CD8 T 细胞的功能,并与 PTEN 缺失黑色素瘤中的 PI3Kβ 抑制协同作用。
Clin Cancer Res. 2019 Nov 1;25(21):6406-6416. doi: 10.1158/1078-0432.CCR-19-1259. Epub 2019 Aug 1.
10
PD-L1 detection using Zr-atezolizumab immuno-PET in renal cell carcinoma tumorgrafts from a patient with favorable nivolumab response.使用 Zr-atezolizumab 免疫 PET 检测对具有良好 nivolumab 反应的患者的肾细胞癌肿瘤移植物中的 PD-L1 表达。
J Immunother Cancer. 2019 Jun 3;7(1):144. doi: 10.1186/s40425-019-0607-z.